To determine whether the phosphorylation of tau decreases after the suppression and activation of AD-related genes and inflammatory pathways and cytokines, we verified the concentration of phosphorylated tau in neuroblastoma cells after treatment with saponins, using western blotting. The gene discussed is MAPT; the disease is neuroblastoma.